Literature DB >> 17823025

The fate of the unexpected positive intraoperative cultures after revision total knee arthroplasty.

Robert L Barrack1, Ajay Aggarwal, R Stephen J Burnett, John C Clohisy, Elie Ghanem, Peter Sharkey, Javad Parvizi.   

Abstract

Of a consecutive series of 692 revision total knees at 3 centers, intraoperative cultures were unexpectedly found to be positive in 41 cases (5.9%). Of the 41, 29 (71%) cases had a single positive intraoperative culture and were determined to be a probable false positive based on absence of any other evidence of infection, of which 5 were treated with extended course of intravenous antibiotics after hospital discharge and the remaining 24 received no further treatment. None of these 24 patients manifested any sign of infection at follow-up, averaging 46 months (range, 24-74 months). Twelve patients were determined to have probable type 1 periprosthetic infection, 11 of which were treated with a course of antibiotics. Two of these patients became reinfected within a year. A single positive intraoperative culture after revision total knee arthroplasty does not mandate further treatment in the absence of any other signs of infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17823025     DOI: 10.1016/j.arth.2007.03.029

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  21 in total

1.  Diagnosis of infected total knee: findings of a multicenter database.

Authors:  Javad Parvizi; Elie Ghanem; Peter Sharkey; Ajay Aggarwal; R Stephen J Burnett; Robert L Barrack
Journal:  Clin Orthop Relat Res       Date:  2008-09-10       Impact factor: 4.176

2.  CORR Insights®: False-positive Cultures After Native Knee Aspiration: True or False.

Authors:  Daniel Schlatterer
Journal:  Clin Orthop Relat Res       Date:  2017-01-11       Impact factor: 4.176

Review 3.  [Periprosthetic infection].

Authors:  C Perka; N Haas
Journal:  Chirurg       Date:  2011-03       Impact factor: 0.955

Review 4.  Unexpected positive intraoperative cultures (UPIC) in revision Hip and knee arthroplasty- A review of the literature.

Authors:  Prabhudev Prasad Purudappa; Om Prakash Sharma; Sruthi Priyavadana; Senthil Sambandam; Jorge A Villafuerte
Journal:  J Orthop       Date:  2019-07-02

5.  Detection of periprosthetic infections with use of ribosomal RNA-based polymerase chain reaction.

Authors:  Patrick F Bergin; Jason D Doppelt; William G Hamilton; Gudrun E Mirick; Angela E Jones; Supatra Sritulanondha; Jeannine M Helm; Rocky S Tuan
Journal:  J Bone Joint Surg Am       Date:  2010-03       Impact factor: 5.284

6.  Mark B. Coventry Award: synovial C-reactive protein: a prospective evaluation of a molecular marker for periprosthetic knee joint infection.

Authors:  Javad Parvizi; Christina Jacovides; Bahar Adeli; Kwang Am Jung; William J Hozack
Journal:  Clin Orthop Relat Res       Date:  2012-01       Impact factor: 4.176

7.  Method of intraoperative tissue sampling for culture has an effect on contamination risk.

Authors:  Antonia F Chen; Meredith Menz; Priscilla K Cavanaugh; Javad Parvizi
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-09-12       Impact factor: 4.342

8.  False-positive Cultures After Native Knee Aspiration: True or False.

Authors:  Jason M Jennings; Douglas A Dennis; Raymond H Kim; Todd M Miner; Charlie C Yang; David C McNabb
Journal:  Clin Orthop Relat Res       Date:  2017-07       Impact factor: 4.176

9.  Evaluation of sonicate fluid cultures in comparison to histological analysis of the periprosthetic membrane for the detection of periprosthetic joint infection.

Authors:  Viktor Janz; Georgi I Wassilew; Olaf Hasart; Georg Matziolis; Stephan Tohtz; Carsten Perka
Journal:  Int Orthop       Date:  2013-03-24       Impact factor: 3.075

10.  The routine use of atypical cultures in presumed aseptic revisions is unnecessary.

Authors:  Anthony T Tokarski; Joseph O'Neil; Carl A Deirmengian; Joseph Ferguson; Gregory K Deirmengian
Journal:  Clin Orthop Relat Res       Date:  2013-10       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.